Market Scope
Bromelainmarket is all set to touch USD 1,055.1 million by 2027, suggests the latest
study by MRFR (Market Research Future. MRFR also expects the market’s growth
rate to be 4.60% over the review period (between 2018 and 2025). We will
provide COVID-19 impact analysis with the report, along with all the extensive
key developments in the market post the coronavirus disease outbreak.
Leading Vendors
KrishnaEnzytech Pvt. Ltd. (India), Advanced Enzyme Technologies (India), Enzybel Group
(Belgium), Fooding Group Limited (China), Changsha Natureway Co., Ltd. (China),
Enzyme Development Corporation (U.S.), Creative Enzymes (U.S.), Hong Mao
Biochemicals Co. Ltd. (Thailand), Nutriteck (Canada), Food State Company
(U.K.), are some of the top vendors in the global bromelain market.
Top Boosters and Challenges
Growth ofindustries like bakery, dietary supplements, beverage and cosmetics as key
end-users for bromelain in countries such as Indonesia, the U.S., France,
Germany, India, South Africa, Brazil and China can translate into heightened
product demand in the years to come. Bromelain’s use in the healthcare industry
has been increasing at a promising rate, given the intense R&D activities
to expand the product’s application scope for the treatment of HIV, cancer and
inflammatory diseases such as coeliac disease, asthma, glomerulonephritis,
hepatitis, as well as autoimmune diseases.
Theescalating disposable income and the amplified number of end-users in the
global market can result in significant business growth during the evaluation
period. One such end-user is the cosmetics industry, which has been integrating
bromelain as a key ingredient in various formulations. Besides, the market has
also been bolstered by the strong demand for natural ingredients and the surge
in the setting up of various biorefinery plants across the world. Skincare
products containing bromelain are used extensively around the world, mainly to
reduce acne, dry skin and wrinkles. On the other hand, the seafood and meat
industry also makes widespread demand for the target product, for improving the
tenderness of pork, beef, squids and chicken.
It isexpected that the heightened demand for bromelain in the health care industry
can offer attractive opportunities to the market leaders in the years to come.
Intense R&D activities being conducted by renowned firms to boost the
application scope of bromelain market analysis, especially in the healthcare
industry, is working in the market’s favor. To cite a reference, in September2020, researchers combined anthocyanin-richextracts derived from tart cherry and hawthorn berries with bromelain extracted
from pineapple, to showcase that the end result can help enhance the
endothelial function and bring down the systolic blood pressure. Thecombination of bromelain and anthocyanin has led to considerable reductions in
the systolic blood pressure in the recent past.
Segmental Review
Bromelainindustry has been extensively reviewed in the MRFR report, with source,type, and application considered as key segments for an enhanced understanding
of the latest trends.
Sourcesmentioned in the report are fruits as well as stems. The best source is
considered to be stem, which acquired a share of 88% in the global bromelain market
share in 2022, while fruits managed to seize a share of 12% the same year.
Stems segment can reach a valuation of USD 931.6 million by 2025, whereas
fruits can expand to approximately USD 123.4 million by 2025 at a rate of
4.32%.
The typesof bromelain market are 1,200 GDU/g, 2,000 GDU/g, 2,500 GDU/g, and more. The
2,000 GDU/g segment can be in the leading position in the coming years while
the 2,500 GDU/g segment can advance at the highest rate of 4.94% to reach close
to USD 281.3 million by 2025.
Theapplications of bromelain market are healthcare, food & beverages, dietary
supplements, and more. The dietary supplements segment, in 2017, accounted for
a share of 39.6% in the market, trailed by healthcare with a share of 35.6% and
food & beverages with a 19.4% share. The others segment claimed a share of
5.4% in the global bromelain market. Dietary supplements segment can expand to
USD 425.0 million by 2025 and the healthcare segment will touch USD 378.4
million by the same year. Healthcare segment’s growth rate is anticipated to be
6.64% between 2018 and 2025.
Regional Insight
Regionally,the bromelain industry has been studied with respect to North America, Asia
Pacific or APAC and Europe, along with RoW or Rest-of-the-World.
Since 2017,North America has remained the top performing in bromelain market, with Europe,
APAC and RoW right behind. North America’s formidable position in the global
market is the outcome of the burgeoning meat industry and the high uptake of
dietary supplements among consumers. The high uptake of energy-efficient
technologies and the escalating number of R&D activities for the
development of high quality products in the region can present attractive
opportunities to the major players. Apart from this, the soaring use of natural
enzymes for developing various medications could also foster the product demand
in the years to follow.
Europe hasbeen second highest gainer since 2017, thanks to the high use of bromelain as a
meat tenderizing agent in processed foods and ready-to-eat products. The
escalating use of bromelain tendonitis in the cosmetics industry coupledwith the extensive adoption as a dietary supplement, especially in Germany can
also benefit the European market.
NOTE: Our Team of Researchers are Studying Covid19 andits Impact on Various Industry Verticals and wherever required we will be
considering Covid19 Footprints for Better Analysis of Market and Industries.
Cordially get in Touch for More Details.
Contact us:
Market Research Future (part of Wantstats Research andMedia Private Limited), 99 Hudson Street,5Th Floor, New York, New York10013, United States of America
